Literature DB >> 8087982

ELISA of IgG antibody to oxidized low-density lipoprotein: effects of blocking buffer and method of data expression.

W Y Craig1, S E Poulin, C P Nelson, R F Ritchie.   

Abstract

We describe an ELISA for serum IgG antibodies against malondialdehyde-modified low-density lipoprotein (mLDL). Optimal antigen concentration, serum dilution, and dilution of enzyme-conjugated second antibody were 25 mg/L, 1:250, and 1:5000, respectively, when 5 g/L human serum albumin was used for blocking. When data were expressed as mLDL/LDL (the ratio of IgG binding to mLDL vs LDL), within-run and between-run CVs were 7.0% and 8.9%, respectively. Antibody concentrations expressed as mLDL/LDL or as mLDL-LDL (the difference between IgG binding to mLDL and to LDL) were higher in women with systemic lupus erythematosus (n = 20) than in controls (n = 20) (P < 0.001). With bovine serum albumin or Superblock blocking buffers, only the mLDL-LDL data were significant. Thus, the choice of blocking agent and the method of data expression should be carefully considered when assaying IgG antibodies against mLDL.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087982

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

1.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice.

Authors:  Giuseppina Caligiuri; Antonino Nicoletti; Bruno Poirier; Göran K Hansson
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.

Authors:  H A Schenkein; C R Berry; D Purkall; J A Burmeister; C N Brooks; J G Tew
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus.

Authors:  Yevgeniy Y Studentsov; Mark Schiffman; Howard D Strickler; Gloria Y F Ho; Yuk-Ying Susana Pang; John Schiller; Rolando Herrero; Robert D Burk
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Adaptive walks with noisy fitness measurements.

Authors:  B Levitan; S Kauffman
Journal:  Mol Divers       Date:  1995-09       Impact factor: 2.943

5.  Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study.

Authors:  Qi Chen; Steven E Reis; Candace Kammerer; Wendy Craig; Dennis M McNamara; Richard Holubkov; Barry L Sharaf; George Sopko; Daniel F Pauly; C Noel Bairey Merz; M Ilyas Kamboh
Journal:  J Lipid Res       Date:  2011-01-20       Impact factor: 5.922

6.  Autoantibodies to malondialdehyde-modified epitope in connective tissue diseases and vasculitides.

Authors:  A Amara; J Constans; C Chaugier; A Sebban; L Dubourg; E Peuchant; J L Pellegrin; B Leng; C Conri; M Geffard
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  Effects of fluvastatin on plasma levels of low-density lipoprotein subfractions, oxidized low-density lipoprotein, and soluble adhesion molecules: a twenty-four-week, open-label, dose-increasing study.

Authors:  Yasuhiko Homma; Koichiro Homma; Shinichi Iizuka; Kamon Iigaya
Journal:  Curr Ther Res Clin Exp       Date:  2003-04

8.  Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations.

Authors:  Abdullatif Taha Babakr; Osman Mohamed Elsheikh; Abdullah A Almarzouki; Adel Mohamed Assiri; Badr Eldin Elsonni Abdalla; Hani Yousif Zaki; Samir H Fatani; EssamEldin Mohamed NourEldin
Journal:  Diabetes Metab Syndr Obes       Date:  2014-10-24       Impact factor: 3.168

9.  Cardiac Affection in Type 1 Diabetic Patients in Relation to Omentin.

Authors:  Soha M Abd El Dayem; Ahmed A Battah; Amal El Shehaby
Journal:  Open Access Maced J Med Sci       Date:  2015-12-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.